Joshua Jones, MD
ASCO EXPERT Joshua Jones, MD, Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania, Philadelphia, commented on the study at a press briefing.
“This is a case where less is more. This is an important study and the first to show equal outcomes and meaningful benefits with a short vs a longer course of radiation therapy,” Dr. Jones said. “Questions still remain about the optimal treatment approach for patients with longer anticipated survival as the SCORAD III study only reviewed outcomes up to 8 weeks after radiotherapy.”
“Spinal cord compression is a debilitating condition that many patients with advanced cancer experience,” he continued. “Until now, patients often had to spend multiple days traveling back and forth to undergo radiation treatments. This study finding means that without compromising care, we can help patients have more time to focus on the things they enjoy, instead of on the cancer.” ■
DISCLOSURE: Dr. Jones reported no conflicts of interest.
